To examine the effects of NAD+ precursors on the development and progression of FRDA-like pathology in mice, we employed the shFxn transgenic mouse model, a doxycycline-inducible Tet-on system driving an shRNA that silences frataxin mRNA throughout the entire body (38). This evidence concerns the gene FXN and Friedreich ataxia.